A DESCRIPTIVE ANALYSIS OF COSTS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH BRONCHIOLITIS OBLITERANS SYNDROME (BOS) FOLLOWING LUNG TRANSPLANTATION

被引：0
|
作者：
Sacks, N. [1 ]
Sheshadri, A. [2 ]
Healey, B. [3 ]
Raza, S. [3 ]
Cyr, P. L. [3 ]
Boerner, G. [4 ]
Huang, H. [5 ]
机构：
[1] Milestone Pharmaceut Inc, Boston, MA USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Precis Hlth Econ & Outcomes Res, Boston, MA USA
[4] Breath Therapeut GmbH, Munich, Germany
[5] Houston Methodist Hosp, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMU10
引用
收藏
页码：S146 / S147
页数：2
相关论文
共 50 条
  • [1] Bronchiolitis obliterans syndrome and additional costs of lung transplantation
    van den Berg, JWK
    van Enckevort, PJ
    TenVergert, EM
    Postma, DS
    van der Bij, W
    Koëter, GH
    [J]. CHEST, 2000, 118 (06) : 1648 - 1652
  • [2] Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome (BOS) following lung transplantation
    Yates, B.
    Ward, C.
    Murphy, D.
    Forrest, I.
    Fisher, A. J.
    Lordan, J.
    Corris, P. A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2005, 24 (02): : S102 - S102
  • [3] THE ECONOMIC BURDEN OF BRONCHIOLITIS OBLITERANS SYNDROME (BOS) IN LUNG TRANSPLANTATION PATIENTS WITH MEDICARE COVERAGE
    Huang, H.
    Sacks, N.
    Healey, B.
    Cyr, P. L.
    Henig, N. R.
    [J]. VALUE IN HEALTH, 2020, 23 : S351 - S351
  • [4] Analysis of risk factors for the development of Bronchiolitis Obliterans Syndrome (BOS) after lung transplantation
    Burton, C. M.
    Carlsen, J.
    Scheike, T.
    Andersen, C. B.
    Iversen, M.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S90 - S90
  • [5] BRONCHIOLITIS OBLITERANS SYNDROME AND SURVIVAL FOLLOWING LUNG TRANSPLANTATION FOR PATIENTS WITH SARCOIDOSIS
    Wille, K. M.
    Gaggar, A.
    Hajari, A. S.
    Leon, K. J.
    Barney, J. B.
    Smith, K. H.
    Pajaro, O.
    Wang, W.
    Oster, R. A.
    McGiffin, D. C.
    Young, K. R.
    [J]. SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2008, 25 (02) : 117 - 124
  • [6] Risk factors for the development of bronchiolitis obliterans syndrome (BOS) after lung transplantation
    Scheed, A.
    Jaksch, P.
    Ghanim, B.
    Taghavi, S.
    Lang, G.
    Aigner, C.
    Klepetko, W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2011, 123 (17-18) : A28 - A28
  • [7] Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation
    Zheng, L
    Walters, EH
    Ward, C
    Wang, N
    Orsida, B
    Whitford, H
    Williams, TJ
    Kotsimbos, T
    Snell, GI
    [J]. THORAX, 2000, 55 (01) : 53 - 59
  • [8] Economic Burden of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant Patients
    Sacks, N. C.
    Healey, B.
    Cyr, P. L.
    Henig, N. R.
    Huang, H. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S364 - S365
  • [9] BRONCHIOLITIS OBLITERANS SYNDROME (BOS) IS NOT SPECIFIC FOR BRONCHIOLITIS OBLITERANS IN PEDIATRIC LUNG TRANSPLANT (LTx)
    Towe, Christopher
    Ogborn, Arthur C.
    Ferkol, Thomas
    Sweet, Stuart
    Huddleston, Charles
    Faro, Albert
    [J]. PEDIATRIC TRANSPLANTATION, 2011, 15 : 126 - 127
  • [10] Bronchiolitis obliterans following lung transplantation
    Al-Githmi, Iskander
    Batawil, Nadia
    Shigemura, Norihisa
    Hsin, Michael
    lee, Tak Wai
    He, Gue-Wei
    Yim, Anthony
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2006, 30 (06) : 846 - 851
12345